EF2: S-Thalidomide
EF2 is a Ligand Of Interest in 8BC7 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8BC7_EF2_A_202 | 54% | 51% | 0.138 | 0.904 | 0.8 | 1.08 | - | 1 | 0 | 0 | 100% | 1 |
| 8BC7_EF2_C_202 | 16% | 69% | 0.26 | 0.832 | 0.52 | 0.68 | - | - | 0 | 0 | 100% | 1 |
| 5AMI_EF2_B_151 | 95% | 4% | 0.069 | 0.975 | 2.56 | 3.03 | 6 | 13 | 0 | 0 | 100% | 1 |
| 5YJ0_EF2_n_501 | 93% | 12% | 0.07 | 0.963 | 2.17 | 1.91 | 4 | 11 | 0 | 0 | 100% | 1 |
| 5AMJ_EF2_A_151 | 92% | 5% | 0.081 | 0.971 | 2.65 | 2.76 | 8 | 10 | 0 | 0 | 100% | 1 |
| 7PSO_EF2_B_202 | 91% | 7% | 0.083 | 0.97 | 2.12 | 2.68 | 5 | 12 | 0 | 0 | 100% | 1 |
| 4V2Y_EF2_B_151 | 91% | 4% | 0.072 | 0.958 | 2.78 | 3.08 | 6 | 13 | 0 | 0 | 100% | 1 |
